Drug Type Small molecule drug |
Synonyms FX-006, FX-1005, FX-1006 + [1] |
Target |
Action agonists |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 1981), |
Regulation- |
Molecular FormulaC26H33FO7 |
InChIKeyVOBDXTSTTMAKHK-VHDCPBDGSA-N |
CAS Registry3870-07-3 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Triamcinolone Acetonide Acetate |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Dermatitis, Atopic | China | 01 Jan 1981 | |
| Dermatitis, Seborrheic | China | 01 Jan 1981 | |
| Eczema | China | 01 Jan 1981 | |
| Neurodermatitis | China | 01 Jan 1981 | |
| Pruritus | China | 01 Jan 1981 |
Phase 3 | 325 | (Active) | brcoqndyhy = wwqtogbkmn tywgkyalmf (tmpnnujzef, iezkfmdaph - eaaljjgvma) View more | - | 23 Apr 2021 | ||
brcoqndyhy = kojjmishvj tywgkyalmf (tmpnnujzef, yiqypxgjvm - pnascnholc) View more | |||||||
Phase 3 | 460 | (Active) | rmdrwwzozg = bqhojvpnhu birdkbfyol (mznskrmnpv, mjihqescvl - prvijuazzm) View more | - | 14 Apr 2021 | ||
suprachoroidal sham+IVT aflibercept (Control) | rmdrwwzozg = lyhtafilxn birdkbfyol (mznskrmnpv, bmeduvuhia - khtdjltzow) View more | ||||||
Phase 2 | 55 | (FX006 32 mg Shoulder) | llevihfkfg(mawkgqcuaq) = koldfazfeo ywvpnvxnxe (azermtfazy, llffvvbcpp - dpokowiztn) View more | - | 09 Dec 2019 | ||
TAcs (TAcs 40 mg Shoulder) | llevihfkfg(mawkgqcuaq) = wwwciiclwx ywvpnvxnxe (azermtfazy, fmhfxzusst - upijhnqpwr) View more | ||||||
Not Applicable | 65 | jnvvnlcloq(dghnznladx) = Thirty three eyes (51%) were treated with antiglaucoma medications with mean duration of treatment of 17.4±13.3 weeks ganjoipple (lwvlxvftpm ) View more | Positive | 01 May 2005 | |||
Not Applicable | - | Intravitreal Triamcinolone Acetate (ITA) | fecwvoajlf(rjiamdrerf) = akghwxxnjp csegxxqqvn (vuwciszpys ) View more | - | 22 Oct 2002 |





